Moving agentic AI from demo to R&D acceleration
Collaboration with Microsoft on the Microsoft Discovery agentic platform for scientific R&D reveals that the real impact is acceleration not automation
What does ‘fast enough’ mean in primary care antibiotic prescribing?
Time-to-result is critical for any diagnostic in primary care. Antibiotic prescribing can only be improved if results come fast enough to guide decision making. But what does ‘fast enough’ look like?
Primary care diagnostics are key to addressing antimicrobial resistance
Primary care is the hidden battlefield of antimicrobial resistance. It is here that more than 80% of all antibiotics are prescribed. Our experts are tackling the challenge of equipping primary care physicians with the right diagnostic and decision-making solutions
What is deep tech? A strategy to create value from an enduring, defensible competitive advantage
Back to insights What is deep tech? A strategy to create value from an enduring, defensible competitive advantage What is deep tech? Frankly, deep tech means different things to different people. It’s a term used by some tech start-ups to woo investors. It’s a label...
A promising breakthrough in the fight against glaucoma blindness
What is glaucoma? It’s a condition that represents the leading cause of irreversible blindness worldwide. A team of CC scientists and engineers have made a promising breakthrough for the monitoring of interocular pressure (IOP), a major contributor to glaucoma.
バイオソリューション：今がその時です
This exclusive Capgemini survey reveals that 96% of organisations are already embracing the disruption of biosolutions